Opioid Use Disorder
400
142
177
126
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
45 trials with published results (11%)
Research Maturity
126 completed trials (32% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.5%
14 terminated out of 400 trials
90.0%
+3.5% vs benchmark
12%
48 trials in Phase 3/4
36%
45 of 126 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 126 completed trials
Clinical Trials (400)
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
A Study of Brenipatide in Participants With Opioid Use Disorder
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
A Bundled Intervention to End Opioid Overdoses
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
Cannabidiol in Opioid Use Disorder and Chronic Pain
Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual
Pilot of Mailing Buprenorphine
Telemedicine XR-B for Individuals in Jail
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
Family-Focused Study to Support Medication for Opioid Use Disorder
Women's Opioid Treatment Follow-up Study
The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment
Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care
Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations